ATE412651T1 - Pyrrolopyridinderivate - Google Patents
PyrrolopyridinderivateInfo
- Publication number
- ATE412651T1 ATE412651T1 AT05747418T AT05747418T ATE412651T1 AT E412651 T1 ATE412651 T1 AT E412651T1 AT 05747418 T AT05747418 T AT 05747418T AT 05747418 T AT05747418 T AT 05747418T AT E412651 T1 ATE412651 T1 AT E412651T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrrolopyridine derivatives
- pyrrolopyridine
- derivatives
- Prior art date
Links
- 150000005255 pyrrolopyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0412908A GB0412908D0 (en) | 2004-06-09 | 2004-06-09 | Compounds |
GB0424950A GB0424950D0 (en) | 2004-11-11 | 2004-11-11 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE412651T1 true ATE412651T1 (de) | 2008-11-15 |
Family
ID=34969264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05747418T ATE412651T1 (de) | 2004-06-09 | 2005-06-07 | Pyrrolopyridinderivate |
Country Status (26)
Country | Link |
---|---|
US (1) | US7589206B2 (de) |
EP (1) | EP1753764B1 (de) |
JP (1) | JP2008501758A (de) |
KR (1) | KR20070034049A (de) |
AR (1) | AR050158A1 (de) |
AT (1) | ATE412651T1 (de) |
AU (1) | AU2005251913A1 (de) |
BR (1) | BRPI0511874A (de) |
CA (1) | CA2569887A1 (de) |
DE (1) | DE602005010698D1 (de) |
DK (1) | DK1753764T3 (de) |
ES (1) | ES2317244T3 (de) |
HK (1) | HK1104175A1 (de) |
HR (1) | HRP20090034T3 (de) |
IL (1) | IL179603A0 (de) |
MA (1) | MA28686B1 (de) |
MX (1) | MXPA06014471A (de) |
NO (1) | NO20070067L (de) |
PE (1) | PE20060430A1 (de) |
PL (1) | PL1753764T3 (de) |
PT (1) | PT1753764E (de) |
RU (1) | RU2006147278A (de) |
SI (1) | SI1753764T1 (de) |
TW (1) | TW200611695A (de) |
UY (1) | UY28945A1 (de) |
WO (1) | WO2005121140A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004000260T2 (de) | 2003-07-22 | 2006-08-24 | Arena Pharmaceuticals, Inc., San Diego | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
KR20070034049A (ko) | 2004-06-09 | 2007-03-27 | 글락소 그룹 리미티드 | 피롤로피리딘 유도체 |
KR20070053231A (ko) † | 2004-07-28 | 2007-05-23 | 다케다 야쿠힌 고교 가부시키가이샤 | 피롤로[2,3-c]피리딘 화합물, 그 제조 방법 및 용도 |
CA2579087C (en) | 2004-09-03 | 2012-05-01 | Yuhan Corporation | Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
GB0516379D0 (en) * | 2005-08-09 | 2005-09-14 | Glaxo Group Ltd | Compounds |
AR055601A1 (es) * | 2005-08-09 | 2007-08-29 | Glaxo Group Ltd | Compuestos derivados de imidazopiridina como ligandos de receptores canabinoides |
JP2009536613A (ja) * | 2006-04-07 | 2009-10-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
ES2389958T3 (es) * | 2007-03-21 | 2012-11-05 | Glaxo Group Limited | Uso de derivados de quinolina en el tratamiento del dolor |
GB0705803D0 (en) * | 2007-03-28 | 2007-05-02 | Glaxo Group Ltd | Novel compounds |
EP2254564A1 (de) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Kombinationen mit 3-phenylsulfonyl-8-piperazinyl-1yl-chinolin |
US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
WO2010113834A1 (ja) | 2009-03-30 | 2010-10-07 | アステラス製薬株式会社 | ピリミジン化合物 |
TW201200518A (en) * | 2010-03-10 | 2012-01-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
BR112013003481A8 (pt) * | 2010-07-29 | 2017-12-26 | Astellas Pharma Inc | composto fundido a anel de piridina |
WO2013140342A1 (en) * | 2012-03-19 | 2013-09-26 | Ariel-University Research And Development Company, Ltd. | Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists |
US9567339B2 (en) | 2013-06-26 | 2017-02-14 | Abbvie Inc. | Primary carboxamides as BTK inhibitors |
CA2989343A1 (en) | 2015-06-12 | 2016-12-15 | Yandong Wen | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
BR112018000728A2 (pt) | 2015-07-15 | 2018-09-04 | Axovant Sciences Gmbh | resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo |
US11053241B2 (en) * | 2018-11-30 | 2021-07-06 | Nimbus Lakshmi, Inc. | TYK2 inhibitors and uses thereof |
US11858935B1 (en) | 2023-09-06 | 2024-01-02 | King Faisal University | Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors |
US11891394B1 (en) | 2023-09-06 | 2024-02-06 | King Faisal University | Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3379404D1 (en) * | 1982-12-29 | 1989-04-20 | Kureha Chemical Ind Co Ltd | Cephalosporin derivatives |
CA2031927A1 (en) | 1989-12-27 | 1991-06-28 | Imperial Oil Limited | Method for improving the activity maintenance of a plasma initiator |
WO1991009598A1 (en) | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
US5112820A (en) * | 1990-03-05 | 1992-05-12 | Sterling Drug Inc. | Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof |
GB9109246D0 (en) | 1991-04-30 | 1991-06-19 | Ici Plc | Nitrogen derivatives |
DE4129603A1 (de) | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
TW263504B (de) | 1991-10-03 | 1995-11-21 | Pfizer | |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5468757A (en) | 1994-01-31 | 1995-11-21 | Eli Lilly And Company | 6-azaindole thromboxane synthase inhibitors |
PL181323B1 (pl) | 1994-02-18 | 2001-07-31 | Boehringer Ingelheim Pharma | 2-heteroarylo-5,11-dihydro-6H-dipirydo[3,2-b:2’,3'-e][1,4] diazepinyi ich zastosowanie w zapobieganiu i leczeniu zakazen HIV PL PL PL |
GB9420521D0 (en) | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
US5589482A (en) | 1994-12-14 | 1996-12-31 | Pfizer Inc. | Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
JPH0920779A (ja) | 1995-05-01 | 1997-01-21 | Japan Tobacco Inc | 縮合ヘテロ5員環アゼピン化合物類及びその医薬用途 |
GB9610811D0 (en) | 1996-05-23 | 1996-07-31 | Pharmacia Spa | Combinatorial solid phase synthesis of a library of indole derivatives |
US6696448B2 (en) | 1996-06-05 | 2004-02-24 | Sugen, Inc. | 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors |
AU4054197A (en) | 1996-08-14 | 1998-03-06 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
WO1998050356A1 (en) | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
EP0931872B1 (de) | 1998-01-23 | 2003-04-09 | Voith Paper Patent GmbH | Verfahren zur Entfernung von feinen Verunreinigungen aus einer Faserstoffsuspension |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
CA2342222A1 (en) | 1998-08-31 | 2000-03-09 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
GB9904995D0 (en) | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Substituted aza-oxindole derivatives |
WO2000053181A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
EP1165075A4 (de) | 1999-03-10 | 2002-04-10 | Merck & Co Inc | 6-azaindolverbindungen als antagonisten des gonadoliberins |
CA2367116A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
WO2000053178A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
CA2366615A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
WO2000053185A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
CA2390948A1 (en) | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
WO2000075145A1 (en) | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1254115A2 (de) | 2000-02-11 | 2002-11-06 | Bristol-Myers Squibb Company | Cannabinoid-rezeptor modulatoren, verfahren zu ihrer herstellung, und verwendung der cannabinoid-rezeptor modulatoren um respiratorische und nicht respiratorische krankheiten zu behandeln |
US20020061892A1 (en) | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
EP1132389A1 (de) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit |
US20020091124A1 (en) | 2000-04-26 | 2002-07-11 | Thomas Beckers | 2-acyl indole derivatives and their use as antitumor agents |
NZ521978A (en) | 2000-04-28 | 2004-10-29 | Acadia Pharm Inc | Compounds that affect cholinergic receptors and are particularly muscarinic agonists |
AU2001284823B2 (en) | 2000-08-14 | 2006-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
AU2001288714A1 (en) | 2000-09-06 | 2002-03-22 | Ortho-Mcneil Pharmaceutical, Inc. | A method for treating allergies |
MXPA03001962A (es) | 2000-09-06 | 2004-03-26 | Johnson & Johnson | Metodo para tratar alergias utilizando pirazoles sustituidos. |
EP1324985A4 (de) | 2000-10-02 | 2004-10-06 | Merck & Co Inc | Hemmstoffe der prenyl-protein transferase |
WO2002057246A2 (en) | 2001-01-17 | 2002-07-25 | Amura Therapeutics Limited | Inhibitors of cruzipain and other cysteine proteases |
RS52489B (en) | 2001-02-02 | 2013-02-28 | Bristol-Myers Squibb Company | COMPOSITION AND ANTI-VIRUS ACTIVITY OF DERIVATIVES OF SUBSTITUTED AZAINDOLOXSOACETATE PIPERAZINE |
US20030207910A1 (en) | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
US6951848B2 (en) | 2001-03-12 | 2005-10-04 | Millennium Pharmaceuticals, Inc., | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
ATE348097T1 (de) | 2001-04-09 | 2007-01-15 | Chiron Corp | Guanidinoverbindungen als melanocortin-4-rezeptor (mc4-r) agonisten |
US7205306B2 (en) | 2001-05-14 | 2007-04-17 | Bristol-Myers Squibb Pharma Company | Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
US20040235867A1 (en) | 2001-07-24 | 2004-11-25 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
DE10143079A1 (de) | 2001-09-03 | 2003-05-15 | Zentaris Ag | Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel |
US7115741B2 (en) | 2001-09-06 | 2006-10-03 | Levy Daniel E | 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds |
ES2278064T3 (es) | 2001-10-19 | 2007-08-01 | Transtech Pharma Inc. | Derivados de beta-carbolina como inhibidores de ptp. |
DE10152306A1 (de) | 2001-10-26 | 2003-07-24 | Asta Medica Ag | 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften |
TW200301251A (en) | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
DE60309852T2 (de) | 2002-03-27 | 2007-06-06 | Glaxo Group Ltd., Greenford | Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden |
WO2003087087A2 (en) | 2002-04-09 | 2003-10-23 | Astex Technology Limited | Heterocyclic compounds and their use as modulators of p38 map kinase |
US20040063744A1 (en) | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
UA78999C2 (en) | 2002-06-04 | 2007-05-10 | Wyeth Corp | 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6 |
US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
TW200403243A (en) | 2002-07-18 | 2004-03-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
MXPA05001389A (es) | 2002-08-06 | 2005-04-28 | Astrazeneca Ab | Piridinas y pirimidinas condensadas con actividad tie2 (tek). |
ATE340785T1 (de) | 2002-08-21 | 2006-10-15 | Glaxo Group Ltd | 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren |
GB0222493D0 (en) | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
CA2499253A1 (en) | 2002-09-30 | 2004-04-08 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
FR2845388B1 (fr) | 2002-10-08 | 2004-11-12 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique |
CA2515571A1 (en) | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
US20040214856A1 (en) | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
KR20070034049A (ko) | 2004-06-09 | 2007-03-27 | 글락소 그룹 리미티드 | 피롤로피리딘 유도체 |
-
2005
- 2005-06-07 KR KR1020077000449A patent/KR20070034049A/ko not_active Application Discontinuation
- 2005-06-07 BR BRPI0511874-3A patent/BRPI0511874A/pt not_active IP Right Cessation
- 2005-06-07 SI SI200530497T patent/SI1753764T1/sl unknown
- 2005-06-07 PE PE2005000651A patent/PE20060430A1/es not_active Application Discontinuation
- 2005-06-07 ES ES05747418T patent/ES2317244T3/es active Active
- 2005-06-07 AU AU2005251913A patent/AU2005251913A1/en not_active Abandoned
- 2005-06-07 US US11/570,099 patent/US7589206B2/en not_active Expired - Fee Related
- 2005-06-07 PL PL05747418T patent/PL1753764T3/pl unknown
- 2005-06-07 EP EP05747418A patent/EP1753764B1/de active Active
- 2005-06-07 TW TW094118669A patent/TW200611695A/zh unknown
- 2005-06-07 DK DK05747418T patent/DK1753764T3/da active
- 2005-06-07 DE DE602005010698T patent/DE602005010698D1/de active Active
- 2005-06-07 AT AT05747418T patent/ATE412651T1/de not_active IP Right Cessation
- 2005-06-07 UY UY28945A patent/UY28945A1/es unknown
- 2005-06-07 JP JP2007526300A patent/JP2008501758A/ja not_active Withdrawn
- 2005-06-07 AR ARP050102327A patent/AR050158A1/es unknown
- 2005-06-07 RU RU2006147278/04A patent/RU2006147278A/ru not_active Application Discontinuation
- 2005-06-07 PT PT05747418T patent/PT1753764E/pt unknown
- 2005-06-07 CA CA002569887A patent/CA2569887A1/en not_active Abandoned
- 2005-06-07 MX MXPA06014471A patent/MXPA06014471A/es unknown
- 2005-06-07 WO PCT/EP2005/006182 patent/WO2005121140A1/en active Application Filing
-
2006
- 2006-11-27 IL IL179603A patent/IL179603A0/en unknown
- 2006-12-28 MA MA29569A patent/MA28686B1/fr unknown
-
2007
- 2007-01-04 NO NO20070067A patent/NO20070067L/no not_active Application Discontinuation
- 2007-08-16 HK HK07108940.7A patent/HK1104175A1/xx not_active IP Right Cessation
-
2009
- 2009-01-20 HR HR20090034T patent/HRP20090034T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1753764A1 (de) | 2007-02-21 |
AR050158A1 (es) | 2006-10-04 |
JP2008501758A (ja) | 2008-01-24 |
DK1753764T3 (da) | 2009-02-16 |
UY28945A1 (es) | 2006-01-31 |
WO2005121140A1 (en) | 2005-12-22 |
HK1104175A1 (en) | 2008-01-04 |
ES2317244T3 (es) | 2009-04-16 |
SI1753764T1 (sl) | 2009-02-28 |
KR20070034049A (ko) | 2007-03-27 |
IL179603A0 (en) | 2007-05-15 |
CA2569887A1 (en) | 2005-12-22 |
PT1753764E (pt) | 2009-01-28 |
US20070219229A1 (en) | 2007-09-20 |
PL1753764T3 (pl) | 2009-04-30 |
RU2006147278A (ru) | 2008-07-20 |
TW200611695A (en) | 2006-04-16 |
EP1753764B1 (de) | 2008-10-29 |
PE20060430A1 (es) | 2006-05-25 |
BRPI0511874A (pt) | 2008-01-15 |
US7589206B2 (en) | 2009-09-15 |
DE602005010698D1 (de) | 2008-12-11 |
MXPA06014471A (es) | 2007-03-21 |
NO20070067L (no) | 2007-02-09 |
MA28686B1 (fr) | 2007-06-01 |
AU2005251913A1 (en) | 2005-12-22 |
HRP20090034T3 (en) | 2009-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2019034I2 (el) | 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια | |
DK1753764T3 (da) | Pyrrolopyridin-derivater | |
ATE415400T1 (de) | Pyrazolopyridinderivate | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
ATE540935T1 (de) | Chinazolinderivate | |
ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
DK1611131T3 (da) | Pyrazolopyridin-derivater | |
DE602005012636D1 (de) | Erung | |
ATE392425T1 (de) | Thiazolyl-dihydro-indazole | |
ATE520680T1 (de) | Hiv-hemmende 5-heterocyclylpyrimidine | |
ATE459633T1 (de) | Makrolide | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
NO20043825D0 (no) | Bolgekraftverk | |
DE602005018177D1 (de) | Drehzerstäubungskopf-lackiervorrichtung | |
DK1740574T3 (da) | 4-amino-5-cyanopyrimidinderivater | |
ATE369347T1 (de) | Trimere makrocyclisch substituierte halogen- benzolderivate | |
ATE389633T1 (de) | Omega-phenyloctanamide | |
DE112005000794T5 (de) | Urethanspritzpistolenanordnung | |
AT500249A3 (de) | Scheibenegge | |
ATE489386T1 (de) | Naphthyridin-derivate | |
FI20045334A0 (fi) | Kasettipatteri |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1753764 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |